IN-VIVO EVALUATION OF SPRAY FORMULATIONS OF HUMAN INSULIN FOR NASAL DELIVERY

被引:40
作者
DONDETI, P [1 ]
ZIA, HS [1 ]
NEEDHAM, TE [1 ]
机构
[1] UNIV RHODE ISL,COLL PHARM,DEPT PHARMACEUT,KINGSTON,RI 02881
关键词
INSULIN; HUMAN; NASAL ADMINISTRATION; SPRAY FORMULATION; BIOADHESIVE POLYMER; MICROCRYSTALLINE CELLULOSE; PLASTOID; AMMONIUM GLYCYRRHIZINATE; GLYCYRRHETINIC ACID; SODIUM TAUROCHOLATE;
D O I
10.1016/0378-5173(95)00045-K
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are many ongoing investigations to improve the nasal bioavailability of peptide and protein formulations. The presence of bioadhesive polymers in nasal formulations may increase the residence time of the drugs in the nasal cavity. A combination of bioadhesive polymers with permeation enhancers would seem to further improve nasal bioavailability. In this study, insulin spray formulations containing two bioadhesive polymers (1.5% w/v microcrystalline cellulose (MCC) and 70% w/w Plastoid L50) alone or in combination with the enhancers such as sodium taurocholate (ST), ammonium glycyrrhizinate (AG) or glycyrrhetinic acid (GA) at 1% w/v level, were evaluated in diabetic rabbits. A total volume of 100 mu l of freshly prepared insulin formulation was sprayed into the nasal cavity of each diabetic rabbit. Glucose levels were monitored using a blood glucose assay and serum insulin levels were analyzed using RIA. 5 U/kg insulin in the MCC suspension alone resulted in an absolute bioavailability of 1.96% while Plastoid L50 alone resulted in 2.25% absolute bioavailability. Insulin in the MCC suspension and ST, AG or GA resulted in 8.36, 7.83 and 2.15% bioavailability, respectively. The same formulations produced a hypoglycemic effect in terms of total glucose reductions of 39.12, 15.96 and 9.36% and the maximal decreases in glucose levels were 58.37, 21.8 and 18.61%, respectively. The Plastoid formulation containing 1% ST provided nasal insulin bioavailability of 5.9% with a total glucose reduction of 17.03% and a maximal glucose decrease of 26.56%. Insulin spray formulations containing 1% ST alone and 1% AG alone resulted in bioavailabilities of 7.25 and 3.57%, respectively. These same sprays provided total glucose reductions of 25.08 and 16.97% with maximal glucose decreases of 44.56 and 19.81%, respectively. The presence of benzalkonium chloride and 2-phenylethanol as preservatives in the MCC suspension resulted in higher insulin absorption than the same formulation without preservatives (6.31% vs 1.96%).
引用
收藏
页码:91 / 105
页数:15
相关论文
共 50 条
  • [41] FORMULATION, CHARACTERIZATION AND IN-VIVO APPLICATION OF ORAL INSULIN NANOTECHNOLOGY USING DIFFERENT BIODEGRADABLE POLYMERS: ADVANCED DRUG DELIVERY SYSTEM
    Kassem, Mohamed
    Ali, Amir
    El-Badrawy, Ali
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2018, 9 (09): : 3664 - 3677
  • [42] A comprehensive review of advanced nasal delivery: Specially insulin and calcitonin
    Luo, Dan
    Ni, Xiaoqing
    Yang, Hao
    Feng, Lu
    Chen, Zhaoqun
    Bai, Lan
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 192
  • [43] Insulin delivery through nasal route using thiolated microspheres
    Nema, Tarang
    Jain, Ashish
    Jain, Aviral
    Shilpi, Satish
    Gulbake, Arvind
    Hurkat, Pooja
    Jain, Sanjay K.
    [J]. DRUG DELIVERY, 2013, 20 (05) : 210 - 215
  • [44] β-Cyclodextrin grafting hyperbranched polyglycerols as carriers for nasal insulin delivery
    Zhang, Xuejiao
    Zhang, Xinge
    Wu, Zhongming
    Gao, Xiujun
    Shu, Shujun
    Wang, Zhen
    Li, Chaoxing
    [J]. CARBOHYDRATE POLYMERS, 2011, 84 (04) : 1419 - 1425
  • [45] NASAL ADMINISTRATION OF INSULIN USING BIOADHESIVE MICROSPHERES AS A DELIVERY SYSTEM
    FARRAJ, NF
    JOHANSEN, BR
    DAVIS, SS
    ILLUM, L
    [J]. JOURNAL OF CONTROLLED RELEASE, 1990, 13 (2-3) : 253 - 261
  • [46] Formulation and in-vivo evaluation of Verapamil HCl suppositories
    Hammouda, Y
    Nada, A
    Kasim, N
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1996, 42 (05) : 340 - 344
  • [47] Synthesis and In Vivo Evaluation of Insulin-Loaded Whey Beads as an Oral Peptide Delivery System
    Heade, Joanne
    McCartney, Fiona
    Chenlo, Miguel
    Marro, Olga Moreno
    Severic, Maja
    Kent, Robert
    Bleiel, Sinead B.
    Alvarez, Clara, V
    Griffin, Brendan T.
    Brayden, David J.
    [J]. PHARMACEUTICS, 2021, 13 (05)
  • [48] Gastrointestinal Responsive Polymeric Nanoparticles for Oral Delivery of Insulin: Optimized Preparation, Characterization, and In Vivo Evaluation
    Fang, Yan
    Wang, Qi
    Lin, Xiaojie
    Jin, Xuechao
    Yang, Dongjuan
    Gao, Shan
    Wang, Xiyan
    Yang, Mingshi
    Shi, Kai
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (09) : 2994 - 3002
  • [49] Mucosal Penetrative Polymeric Micelle Formulations for Insulin Delivery to the Respiratory Tract
    Kang, Ji-Hyun
    Jeong, Jin-Hyuk
    Kwon, Yong-Bin
    Kim, Young-Jin
    Shin, Dae Hwan
    Park, Yun-Sang
    Hyun, Soonsil
    Kim, Dong-Wook
    Park, Chun-Woong
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 9195 - 9211
  • [50] STIMULATION OF BUTYRATE ABSORPTION IN THE HUMAN RECTUM IN-VIVO
    HOLTUG, K
    HOVE, H
    MORTENSEN, PB
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 (10) : 982 - 988